The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.
about
Surgical management of localised renal cell carcinomaSurgical management for upper urinary tract transitional cell carcinomaSurgical management of localised prostate cancerSurgical management of localised renal cell carcinomaSurgical management of localised prostate cancerThe Clinician's Toolbox: Assessing the Sexual Impacts of Cancer on Adolescents and Young Adults with Cancer (AYAC)'Trifecta' after radical prostatectomy: is there a standard definition?The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26Longitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancerKey issues affecting quality of life and patient-reported outcomes in prostate cancer: an analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS).Lack of comprehension of common prostate cancer terms in an underserved population.Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development studyLong-term functional outcomes after treatment for localized prostate cancer.A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology GroupDevelopment of prostate cancer research database with the clinical data warehouse technology for direct linkage with electronic medical record system.Data pooling and analysis to build a preliminary item bank: an example using bowel function in prostate cancer.The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397).Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures.ProsCan for men: randomised controlled trial of a decision support intervention for men with localised prostate cancer.ProsCan for Couples: randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy.Cancer-related communication, relationship intimacy, and psychological distress among couples coping with localized prostate cancer.Long-term continence outcomes in men undergoing radical prostatectomy for clinically localized prostate cancer.Disclosure of diagnosis and treatment among early stage prostate cancer survivors.Living with prostate cancer: randomised controlled trial of a multimodal supportive care intervention for men with prostate cancer.Disrupted sleep in breast and prostate cancer patients undergoing radiation therapy: the role of coping processes.Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.Orthotopic neobladder versus ileal conduit urinary diversion after cystectomy--a quality-of-life based comparisonRecommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.Quality of life as an outcome in clinical trials and cancer care: a primer for surgeons.Does robotic prostatectomy meet its promise in the management of prostate cancer?Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial.Sexual self-schema and depressive symptoms after prostate cancerPreferences of husbands and wives for outcomes of prostate cancer screening and treatment.Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes studyIntimacy-enhancing psychological intervention for men diagnosed with prostate cancer and their partners: a pilot study.Psychosocial interventions to improve quality of life in prostate cancer survivors and their intimate or family partnersMillon Behavioral Medicine Diagnostic (MBMD) Predicts Health-Related Quality of Life (HrQoL) over time among men treated for localized prostate cancer.Achieving optimal delivery of follow-up care for prostate cancer survivors: improving patient outcomes
P2860
Q24186058-3473BCA6-2C90-497D-9BE2-9641DC044B5FQ24235065-6C66EA4F-B3F5-4F0E-9A7A-5B76BA42AC3BQ24236194-88F7C7E1-109B-4A5E-9595-FACC7300F639Q24236818-4ED806D5-C7CE-4C20-BA6F-FE9947B097EDQ24240595-EFE64F75-0E01-432B-B503-06F5441700BFQ26782823-377D39D4-6D47-4FB8-90F2-11CFA2BE51F5Q27026791-ED254693-9EE3-4D7E-A1C5-83FCAB4A29D4Q27311513-73F788C3-4DBC-41EE-A1BC-9F45BAF161BEQ28261683-F08AD6D8-1A6B-4773-9608-E1446AC71E16Q28298672-D9186E8D-8FE2-4B9D-89BD-46D46A28DEC3Q30274829-0F3A7414-86D2-48DE-BF13-0B4A42B43685Q30436410-3B85AB30-EE9B-4A1A-9CF1-2F2224E63738Q30514532-94EB37E0-0149-4E1A-AC45-68F09262BB22Q30542816-F48AAB20-9366-46BE-AA01-A65FCA7B183BQ30613075-EBB9EAB7-CF36-44CC-9305-5F437F8204CCQ30677640-A8B35E0A-5C93-4B99-A97E-F4D855D83880Q30693970-BB22FCCB-6B66-4A2A-9AC1-FA264EE97DB4Q30988028-93B4D1D8-74C4-41FE-86F4-A4994EF9ED24Q31083661-F7905A6A-1EF3-40D8-B14C-4F87E4ED4294Q33166857-902D280F-8409-4A84-B45B-B0D57C39D35DQ33354661-B73B6016-D64F-4339-8724-CD1AE0ED3A1BQ33358563-3F1B534C-EE26-4D4B-9F95-A162705E0ED6Q33689412-4925C302-C507-451E-8F8A-978BDC6D7FDFQ33773296-8EAADB4B-A604-4BF4-B492-B4C1F7C0CCF8Q33798557-42C32C2D-57F9-4DED-9BE3-7694CC8B4CE5Q33972182-4C20395D-8B54-4E2B-B5F4-0E8D4CA9BA15Q34067630-DADE7299-9985-4564-9EB6-AEE08E45A733Q34136485-B45F905B-85B0-43DB-866B-844B85888E53Q34251636-1E8C0C70-2AAC-48EF-8D5E-154A06A8D64EQ34315605-9A1A7CB3-52D7-47C4-8E85-5A1853E2CCE8Q34319606-1FAFE5BF-D72C-4A82-8FD4-6986FA19616EQ34337735-DD38CFD2-E6B0-4066-B7F7-A407FF104097Q34635841-CC52C9F6-57F3-4189-8FD1-C4FB4AEB82A7Q34691750-2A3868D9-DE44-4796-8E45-3610D767F774Q34732064-7FCCFDCF-CC4F-47B5-B638-C413F04C509CQ34742544-4B6FA767-A1AE-4A3B-A98C-C1AA54FD0BE7Q34762059-C10B3C4E-A5BA-4D34-BBBC-FDD450E63C34Q35050930-0EF86192-4AF3-4387-B387-51614CEB56C4Q35141974-EAB0C7B2-7D11-4C68-9CA9-BBEB843AED27Q35212795-40611684-709F-4337-8BF4-94E7B789ED40
P2860
The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
The UCLA Prostate Cancer Index ...... lated quality of life measure.
@en
The UCLA Prostate Cancer Index ...... lated quality of life measure.
@nl
type
label
The UCLA Prostate Cancer Index ...... lated quality of life measure.
@en
The UCLA Prostate Cancer Index ...... lated quality of life measure.
@nl
prefLabel
The UCLA Prostate Cancer Index ...... lated quality of life measure.
@en
The UCLA Prostate Cancer Index ...... lated quality of life measure.
@nl
P2093
P1433
P1476
The UCLA Prostate Cancer Index ...... lated quality of life measure.
@en
P2093
P304
P356
10.1097/00005650-199807000-00007
P577
1998-07-01T00:00:00Z